Freenome, Inc. Investing Cash Flow
Freenome, Inc. (FRNM) reported Investing Cash Flow of $8.16 million for the 6-month period ending 2026-06-30, per its S-1 filed 2026-08-18.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-18
- Freenome, Inc. net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was $8.16M, a 2619.58% increase year-over-year.
- Freenome, Inc. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- Freenome, Inc. net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was $0.00.
- Freenome, Inc. net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was $0.00.
| Period end | Net Cash Provided by (Used in) Investing Activities 0 month | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $8.16M derived: S-1 6 month − S-4/A 3 month · filed 2026-08-18 | $8.16M S-1 · filed 2026-08-18 | $8.16M derived: sum of 3 quarters · filed 2026-08-18 | $8.16M derived: sum of 4 quarters · filed 2026-08-18 | |
| 2026-03-31 | $0.00 S-4/A · filed 2026-06-11 | $0.00 derived: sum of 2 quarters · filed 2026-08-18 | $0.00 derived: sum of 3 quarters · filed 2026-08-18 | $300.00K derived: sum of 4 quarters · filed 2026-08-18 | |
| 2025-12-31 | $0.00 derived: S-1 12 month − 10-Q 9 month · filed 2026-08-18 | $0.00 derived: sum of 2 quarters · filed 2026-08-18 | $300.00K derived: sum of 3 quarters · filed 2026-08-18 | $600.00K S-1 · filed 2026-08-18 | |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − S-1 6 month · filed 2025-11-13 | $300.00K derived: sum of 2 quarters · filed 2026-08-18 | $600.00K 10-Q · filed 2025-11-13 | $600.00K derived: sum of 4 quarters · filed 2026-08-18 | |
| 2025-06-30 | $300.00K derived: S-1 6 month − S-4/A 3 month · filed 2026-08-18 | $600.00K S-1 · filed 2026-08-18 | $600.00K derived: sum of 3 quarters · filed 2026-08-18 | $600.00K derived: sum of 4 quarters · filed 2026-08-18 | |
| 2025-03-31 | $300.00K S-4/A · filed 2026-06-11 | $300.00K derived: sum of 2 quarters · filed 2026-08-18 | $300.00K derived: sum of 3 quarters · filed 2026-08-18 | -$85.95M derived: sum of 4 quarters · filed 2026-08-18 | |
| 2024-12-31 | $0.00 derived: S-1 9 month − 10-Q 6 month · filed 2026-08-18 | $0.00 derived: sum of 2 quarters · filed 2026-08-18 | -$86.25M S-1 · filed 2026-08-18 | ||
| 2024-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-13 | -$86.25M 10-Q · filed 2025-11-13 | |||
| 2024-06-30 | -$86.25M 10-Q · filed 2025-08-13 | ||||
| 2024-03-31 | $0.00 10-Q · filed 2025-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |